One of the most significant challenges in gene therapy is delivering genetic materials effectively to their target within the body.
The LipoX team is currently in the process of developing a product called lipid nanoparticles (LNPs) to address this challenge. These LNPs will efficiently and selectively transport gene-based therapies throughout the body. Researchers: Abdalla Ali, Stanislav Kan & Wei Zhao
Faculty of Medicine, Dentistry and Health Sciences